NASDAQ:NRSN
NeuroSense Therapeutics Ltd.
- Stock
locale
Israel
market
STOCKSindustry
Biotechnologywebsite
www.neurosense-tx.comipo date
Dec 09, 2021
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of treatment for patients suffering from debilitating neurodegenerative diseases. Its lead product, PrimeC, is a novel oral formulation that has completed Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis. The company's preclinical pipeline i...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus